Literature DB >> 17085012

An integrated map of p53-binding sites and histone modification in the human ENCODE regions.

Kiyofumi Kaneshiro1, Shuichi Tsutsumi, Shingo Tsuji, Katsuhiko Shirahige, Hiroyuki Aburatani.   

Abstract

TP53 (tumor protein p53; p53) regulates its target genes under various cellular stresses. By combining chromatin immunoprecipitation with oligonucleotide microarrays, we have mapped binding sites of p53 (p53-BS) in the genome of HCT116 human colon carcinoma cells, along with those of acetylated H3, acetylated H4, and methylated H3-K4. We analyzed a 30-Mb portion of the human genome selected as a representative model by the ENCODE Consortium. In the region, we found 37 p53-BS, of which the p53-binding motif was present in 32 (86%). Acetylated histone H3 and H4 were detected at 14 (38%) and 33 (89%) of the p53-BS, respectively. A significant portion (58%) of H4 acetylation in the p53-BS was not accompanied by H3 acetylation. Acetyl H3 were preferentially located at the 5' and 3' ends of genes, whereas acetyl H4 were distributed widely across the genome. These results provide novel insights into how p53 binding coordinates with histone modification in human.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17085012     DOI: 10.1016/j.ygeno.2006.09.001

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  32 in total

1.  COUP-TFII acts downstream of Wnt/beta-catenin signal to silence PPARgamma gene expression and repress adipogenesis.

Authors:  Masashi Okamura; Hiromi Kudo; Ken-ichi Wakabayashi; Toshiya Tanaka; Aya Nonaka; Aoi Uchida; Shuichi Tsutsumi; Iori Sakakibara; Makoto Naito; Timothy F Osborne; Takao Hamakubo; Sadayoshi Ito; Hiroyuki Aburatani; Masashi Yanagisawa; Tatsuhiko Kodama; Juro Sakai
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-23       Impact factor: 11.205

2.  Genome-wide analysis of the p53 gene regulatory network in the developing mouse kidney.

Authors:  Yuwen Li; Jiao Liu; Nathan McLaughlin; Dimcho Bachvarov; Zubaida Saifudeen; Samir S El-Dahr
Journal:  Physiol Genomics       Date:  2013-09-03       Impact factor: 3.107

3.  Distinct p53 genomic binding patterns in normal and cancer-derived human cells.

Authors:  Krassimira Botcheva; Sean R McCorkle; W R McCombie; John J Dunn; Carl W Anderson
Journal:  Cell Cycle       Date:  2011-12-15       Impact factor: 4.534

4.  Dispersed Chromosomal Stat5b-binding elements mediate growth hormone-activated insulin-like growth factor-I gene transcription.

Authors:  Dennis J Chia; Ben Varco-Merth; Peter Rotwein
Journal:  J Biol Chem       Date:  2010-04-07       Impact factor: 5.157

5.  Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling.

Authors:  Daizo Koinuma; Shuichi Tsutsumi; Naoko Kamimura; Hirokazu Taniguchi; Keiji Miyazawa; Makoto Sunamura; Takeshi Imamura; Kohei Miyazono; Hiroyuki Aburatani
Journal:  Mol Cell Biol       Date:  2008-10-27       Impact factor: 4.272

Review 6.  The expanding universe of p53 targets.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

Review 7.  Versatile functions of p53 protein in multicellular organisms.

Authors:  P M Chumakov
Journal:  Biochemistry (Mosc)       Date:  2007-12       Impact factor: 2.487

8.  PADI4 and tumourigenesis.

Authors:  Xiaotian Chang; Kehua Fang
Journal:  Cancer Cell Int       Date:  2010-03-12       Impact factor: 5.722

9.  Species-specific endogenous retroviruses shape the transcriptional network of the human tumor suppressor protein p53.

Authors:  Ting Wang; Jue Zeng; Craig B Lowe; Robert G Sellers; Sofie R Salama; Min Yang; Shawn M Burgess; Rainer K Brachmann; David Haussler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

10.  Effects of CpG methylation on recognition of DNA by the tumour suppressor p53.

Authors:  Miriana Petrovich; Dmitry B Veprintsev
Journal:  J Mol Biol       Date:  2008-12-06       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.